Claims
- 1. An improved pharmaceutical composition comprising the salt/ion pair of a non-steroidal anti-inflammatory drug and sympathomimetic drug combination.
- 2. The pharmaceutical composition of claim 1 wherein said non-steroidal anti-inflammatory drug is selected from the group consisting of Meclofenamic acid, Salicylic acid, Sulindac, Ibuprofen, Naproxen, Diclofenac and mixtures thereof.
- 3. The pharmaceutical composition of claim 2 wherein said sympathomimetic drug is selected from the group consisting of nasal decongestants and bronchodilators.
- 4. The pharmaceutical composition of claim 3 wherein said non-steroidal anti-inflammatory drug is combined with said sympathomimetic drug in a 1:1 ratio.
- 5. The pharmaceutical composition of claim 4 further comprising pharmaceutically acceptable excipients and non-toxic carrier materials.
- 6. The pharmaceutical composition of claim 5 wherein said composition is incorporated into a therapeutic dosage form selected from the group consisting of capsules, tablets, elixirs, parenterals, suspensions, saches, transdermal patches, suppositories, and topical ointments.
- 7. An improved pharmaceutical composition comprising the salt formed by the acid-base reaction of a non-steroidal anti-inflammatory drug and a sympathomimetic drug,
- 8. An improved pharmaceutical composition comprising an ion pair formed by the acid-base reaction of a non-steroidal anti-inflammatory drug and a sympathomimetic drug,
- 9. The pharmaceutical composition of claim 7 or 8 wherein said non-steroidal anti-inflammatory drug is selected from the group consisting of Meclofenamic acid, Salicylic acid, Sulindac, Ibuprofen, Naproxen, Diclofenac and mixtures thereof.
- 10. The pharmaceutical composition of claim 9 wherein said sympathomimetic drug is selected from the group consisting of nasal decongestants and bronchodialators.
- 11. The pharmaceutical composition of claim 10 wherein said decongestant is selected from the group consisting of pseudoephedrine.
- 12. The pharmaceutical composition of claim 11 wherein said non-steroidal anti-inflammatory drug is combined with said sympathomimetic drug in a 1:1 molar ratio.
- 13. The pharmaceutical composition of claim 12 further comprising pharmaceutically acceptable excipients and non-toxic carrier materials.
- 14. The pharmaceutical composition of claim 13 wherein said composition is incorporated into a therapeutic dosage form selected from the group consisting of capsules, tablets, elixirs, parenterals, suspensions, sachets, transdermal patches, suppositories, and topical ointments.
Parent Case Info
This is a divisional application of copending application Ser. No. 07/942,108 filed Sep. 8, 1992 which is a File Wrapper continuation of U.S. application Ser. No. 07/664,018 filed on Mar. 4, 1991, now abandoned.
US Referenced Citations (5)
Divisions (1)
|
Number |
Date |
Country |
Parent |
942108 |
Sep 1992 |
|
Continuations (1)
|
Number |
Date |
Country |
Parent |
664018 |
Mar 1991 |
|